Product Information
ALLOPURINOL 300 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.0563 per EA under NDC 16729013516. Its NADAC has been published 571 times since Jun 17, 2015.
FDA first approved this application on May 6, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729013516
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
ALLOPURINOLApproval Type
Generic (ANDA)
FDA Application
ANDA203154FDA Approved
5/6/2013
TE Code
AB
On Market Since
4/29/2015
Pharmacological Classes
Price Statistics
The NADAC for ALLOPURINOL 300 MG TABLET has been published 571 times since Jun 17, 2015, and over the history we have for it it has declined 82.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0563 per EA |
|---|---|
| All-time high | $0.3281 (Aug 12, 2015) |
| All-time low | $0.0552 (Apr 22, 2026) |
| 52-week high | $0.0674 |
| 52-week low | $0.0552 |
| Median price | $0.1012 |
| Average price | $0.1345 |
| Largest weekly change | -17.2% (Dec 20, 2017) |
| Weeks tracked | 571 |
| Tracking since | Jun 17, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
-4.4%
1Y
-16.4%
3Y
-29.3%
5Y
-49.4%
All
-82.4%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ALLOPURINOL 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ALLOPURINOL 300 MG TABLET, manufactured by Accord Healthcare Inc., is $0.0563 per EA (NDC 16729013516), effective May 20, 2026.
How has the price of ALLOPURINOL 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for ALLOPURINOL 300 MG TABLET has declined 82.4%. It has been tracked across 571 weekly CMS publications since Jun 17, 2015.
What are the highest and lowest recorded NADAC prices for ALLOPURINOL 300 MG TABLET?
Since Jun 17, 2015, the NADAC for ALLOPURINOL 300 MG TABLET has ranged from a low of $0.0552 (Apr 22, 2026) to a high of $0.3281 (Aug 12, 2015), with a median of $0.1012 per EA.
Are there cheaper alternatives to ALLOPURINOL 300 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ALLOPURINOL 300 MG TABLET, is $0.0546 per EA — about 3% below ALLOPURINOL 300 MG TABLET.
Who manufactures ALLOPURINOL 300 MG TABLET?
ALLOPURINOL 300 MG TABLET (NDC 16729013516) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.